KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,000 | -41.8% | 143,823 | -21.3% | 0.00% | – |
| Q2 2022 | $55,000 | -64.5% | 182,786 | +61.8% | 0.00% | – |
| Q1 2022 | $155,000 | -26.5% | 112,985 | -34.9% | 0.00% | – |
| Q4 2021 | $211,000 | -64.7% | 173,548 | -24.0% | 0.00% | – |
| Q3 2021 | $598,000 | -34.4% | 228,456 | +32.6% | 0.00% | – |
| Q2 2021 | $912,000 | -24.4% | 172,272 | -3.7% | 0.00% | – |
| Q1 2021 | $1,206,000 | -26.8% | 178,912 | -26.3% | 0.00% | – |
| Q4 2020 | $1,647,000 | +90.4% | 242,830 | +110.6% | 0.00% | – |
| Q3 2020 | $865,000 | +27.8% | 115,301 | +79.0% | 0.00% | – |
| Q2 2020 | $677,000 | -77.4% | 64,400 | -81.1% | 0.00% | -100.0% |
| Q1 2020 | $2,999,000 | +316.5% | 341,271 | +74.8% | 0.00% | – |
| Q4 2019 | $720,000 | -29.3% | 195,207 | -27.1% | 0.00% | – |
| Q3 2019 | $1,018,000 | -21.3% | 267,696 | +32.0% | 0.00% | – |
| Q2 2019 | $1,294,000 | +30.6% | 202,811 | +69.1% | 0.00% | – |
| Q1 2019 | $991,000 | +17.8% | 119,902 | -30.3% | 0.00% | – |
| Q4 2018 | $841,000 | +184.1% | 171,968 | +473.2% | 0.00% | – |
| Q3 2018 | $296,000 | +54.2% | 30,000 | +147.9% | 0.00% | – |
| Q1 2018 | $192,000 | – | 12,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |